A clinical pharmacological study of SK-0403
Phase 3
- Conditions
- Type 2 diabetes mellitus
- Registration Number
- JPRN-jRCT2080221260
- Lead Sponsor
- SANWA KAGAKU KENKYUSHO CO.,LTD.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- Male
- Target Recruitment
- 20
Inclusion Criteria
Patients with type 2 diabetes mellitus who have inadequate glycemic control by diet and/or exercise therapies
HbA1C of >= 6.5%, but < 10.0%
fasting blood glucose of >=126mg/dL, but <200mg/dL
1-hour postprandial blood glucose or 2-hour postprandial blood glucose of >=200mg/d
Exclusion Criteria
Patients with type 1 diabetes mellitus
Patients with, or a history of, clinically significant cardiac, renal, hepatic, pulmonary, pancreatic and macrovascular disease
Patients who had taken SK-0403
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pharmacodynamics and Safety
- Secondary Outcome Measures
Name Time Method